Susan Vallow

616 total citations
17 papers, 468 citations indexed

About

Susan Vallow is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Oncology. According to data from OpenAlex, Susan Vallow has authored 17 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Nephrology and 3 papers in Oncology. Recurrent topics in Susan Vallow's work include Renal Diseases and Glomerulopathies (3 papers), Complement system in diseases (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Susan Vallow is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Complement system in diseases (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Susan Vallow collaborates with scholars based in United States, Switzerland and United Kingdom. Susan Vallow's co-authors include Nathaniel P. Katz, Jeff Schein, Milena N. Mareva, Howard G. Birnbaum, Alan G. White, Robert N. Jamison, G. Vorsanger, Steven Ascher, Richard P. Allen and Christopher J. Earley and has published in prestigious journals such as Blood, American Journal of Kidney Diseases and Journal of Pain and Symptom Management.

In The Last Decade

Susan Vallow

16 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Vallow United States 8 186 175 103 101 87 17 468
Kathrin Jobski Germany 13 64 0.3× 50 0.3× 41 0.4× 134 1.3× 62 0.7× 37 517
P. Gretenkort Germany 13 206 1.1× 73 0.4× 338 3.3× 26 0.3× 263 3.0× 28 754
Adam Hurlow United Kingdom 11 227 1.2× 46 0.3× 74 0.7× 19 0.2× 37 0.4× 23 466
Youran Fan United States 9 65 0.3× 95 0.5× 36 0.3× 19 0.2× 43 0.5× 15 465
Milena N. Mareva United States 8 173 0.9× 135 0.8× 74 0.7× 15 0.1× 59 0.7× 8 472
Angela Huskey United States 8 215 1.2× 107 0.6× 120 1.2× 15 0.1× 51 0.6× 16 447
Kitty Lawrence Austria 10 58 0.3× 34 0.2× 38 0.4× 39 0.4× 111 1.3× 16 403
Andrew McKeown United States 14 108 0.6× 21 0.1× 73 0.7× 66 0.7× 68 0.8× 25 394
Kate Jackson Australia 12 206 1.1× 81 0.5× 162 1.6× 13 0.1× 45 0.5× 26 428
L. Saita Italy 12 133 0.7× 32 0.2× 317 3.1× 69 0.7× 62 0.7× 25 574

Countries citing papers authored by Susan Vallow

Since Specialization
Citations

This map shows the geographic impact of Susan Vallow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Vallow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Vallow more than expected).

Fields of papers citing papers by Susan Vallow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Vallow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Vallow. The network helps show where Susan Vallow may publish in the future.

Co-authorship network of co-authors of Susan Vallow

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Vallow. A scholar is included among the top collaborators of Susan Vallow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Vallow. Susan Vallow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Risitano, Antonio M., Austin Kulasekararaj, Jaroslaw P. Maciejewski, et al.. (2025). Patient-reported improvements in paroxysmal nocturnal hemoglobinuria treated with iptacopan from 2 phase 3 studies. Blood Advances. 9(8). 1816–1826. 2 indexed citations
2.
Cella, David, Patrick Y. Wen, Susan Vallow, et al.. (2023). Understanding the patient experience and treatment benefits in patients with non–small‐cell lung cancer with brain metastasis. Cancer Medicine. 12(12). 13637–13648. 2 indexed citations
3.
Castro, Carlos de, Phillip Scheinberg, Susan Vallow, et al.. (2023). Patient Experience Interviews with a Novel Treatment Iptacopan for Paroxysmal Nocturnal Hemoglobinuria. Blood. 142(Supplement 1). 7339–7339. 4 indexed citations
5.
Gordon, Sarah, Alexandra I. Barsdorf, J. A. Cohen, et al.. (2022). Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically. Therapeutic Innovation & Regulatory Science. 56(3). 442–453. 9 indexed citations
6.
Hudgens, Stacie, Louise Newton, Sonya Eremenco, et al.. (2022). Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings. Journal of Patient-Reported Outcomes. 6(1). 119–119. 5 indexed citations
7.
8.
Raymond, Kimberly, et al.. (2022). Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments. Journal of Patient-Reported Outcomes. 6(1). 75–75. 1 indexed citations
9.
Rooij, Belle H. de, Corina van den Hurk, Paz Fernández‐Ortega, et al.. (2022). Development of an updated, standardized, patient-centered outcome set for lung cancer. Lung Cancer. 173. 5–13. 7 indexed citations
10.
Rooij, Belle H. de, Corina van den Hurk, Paz Fernández‐Ortega, et al.. (2022). Development of an Updated, Standardized, Patient-Centered Outcome Set for Lung Cancer. SSRN Electronic Journal.
11.
Vallow, Susan, et al.. (2021). Development and Content Validity of a Novel Myelodysplastic Syndromes Symptom Daily Diary. Blood. 138(Supplement 1). 4654–4654. 1 indexed citations
12.
Mathias, Susan D., Susan Vallow, Debbie S. Gipson, Kevin S. Thorneloe, & Dennis L. Sprecher. (2017). Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire. American Journal of Kidney Diseases. 70(4). 532–540. 10 indexed citations
13.
Hegade, Vinod S., Stuart Kendrick, Robert L. Dobbins, et al.. (2016). BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial. BMC Gastroenterology. 16(1). 71–71. 33 indexed citations
14.
Abetz, Linda, et al.. (2005). Validation of the Restless Legs Syndrome Quality of Life Questionnaire. Value in Health. 8(2). 157–167. 94 indexed citations
15.
White, Alan G., Howard G. Birnbaum, Milena N. Mareva, et al.. (2005). Direct Costs of Opioid Abuse in an Insured Population in the United States. Journal of Managed Care Pharmacy. 11(6). 469–479. 165 indexed citations
16.
Pizzi, Laura, et al.. (2005). Work Loss, Healthcare Utilization, and Costs among US Employees with Chronic Pain. Disease Management & Health Outcomes. 13(3). 201–208. 22 indexed citations
17.
Jamison, Robert N., Jeff Schein, Susan Vallow, et al.. (2003). Neuropsychological effects of long-term opioid use in chronic pain patients. Journal of Pain and Symptom Management. 26(4). 913–921. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026